{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:24:44Z","timestamp":1790645084837,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","burnsjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.burns.2017.03.016","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T19:31:31Z","timestamp":1494963091000},"page":"1464-1472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The use of Biobrane \u00ae  for wound coverage in Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-1267","authenticated-orcid":false,"given":"Alan D.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Blackport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cartotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.burns.2017.03.016_bib0005","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.burns.2017.03.016_bib0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.burns.2017.03.016_bib0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2017.03.016_bib0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0738-081X(98)00011-X","article-title":"Drug-induced toxic epidermal necrolysis","volume":"16","author":"Wolkenstein","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.burns.2017.03.016_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0733-8635(05)70196-0","article-title":"Toxic epidermal necrolysis","volume":"18","author":"Wolkenstein","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.burns.2017.03.016_bib0030","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens Johnson syndrome: a review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.burns.2017.03.016_bib0035","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.burns.2017.03.016_bib0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","article-title":"Drug-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"1","author":"Fritsch","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.burns.2017.03.016_bib0045","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0895-4356(95)00004-N","article-title":"An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods","volume":"48","author":"Kelly","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.burns.2017.03.016_bib0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.BCR.0000216532.71360.9B","article-title":"SCORTEN overestimates mortality in the setting of standardized treatment","volume":"27","author":"Imahara","year":"2006","journal-title":"J Burn Care Res"},{"issue":"January\u2013February (1)","key":"10.1016\/j.burns.2017.03.016_bib0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","article-title":"SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn centre","volume":"29","author":"Cartotto","year":"2008","journal-title":"J Burn Care Res"},{"issue":"March\u2013April (2)","key":"10.1016\/j.burns.2017.03.016_bib0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"issue":"August (2)","key":"10.1016\/j.burns.2017.03.016_bib0065","first-page":"149","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.burns.2017.03.016_bib0070","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.1987.03390160057026","article-title":"Toxic epidermal necrolysis: a step forward in treatment","volume":"257","author":"Heimbach","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.burns.2017.03.016_bib0075","series-title":"Plastic surgery","first-page":"793","article-title":"Exfoliative disorders","author":"Cartotto","year":"2006"},{"key":"10.1016\/j.burns.2017.03.016_bib0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","article-title":"Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids","volume":"204","author":"Halebian","year":"1986","journal-title":"Ann Surg"},{"issue":"May\u2013June (3)","key":"10.1016\/j.burns.2017.03.016_bib0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004630-199005000-00010","article-title":"Biobrane\u00ae wound dressing used in the treatment of toxic epidermal necrolysis: a case report","volume":"11","author":"Sowder","year":"1990","journal-title":"J Burn Care Rehabil"},{"issue":"June (11)","key":"10.1016\/j.burns.2017.03.016_bib0090","first-page":"1477","article-title":"Toxic epidermal necrolysis: a burn-centre challenge","volume":"144","author":"Peters","year":"1991","journal-title":"CMAJ"},{"issue":"August (2)","key":"10.1016\/j.burns.2017.03.016_bib0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000637-199508000-00002","article-title":"Toxic epidermal necrolysis: a review and report of the successful use of Biobrane\u00ae for early wound coverage","volume":"35","author":"Bradley","year":"1995","journal-title":"Ann Plast Surg"},{"issue":"September\u2013October (5)","key":"10.1016\/j.burns.2017.03.016_bib0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00004630-199909000-00013","article-title":"Skin coverage with Biobrane\u00ae biomaterial for the treatment of patients with toxic epidermal necrolysis","volume":"20","author":"Ar\u00e9valo","year":"1999","journal-title":"J Burn Care Rehabil"},{"issue":"February (2)","key":"10.1016\/j.burns.2017.03.016_bib0105","first-page":"160","article-title":"A semisynthetic bilaminar skin substitute used to treat pediatric full-body toxic epidermal necrolysis: wraparound technique in a 17-month-old girl","volume":"140","author":"Bannasch","year":"2004","journal-title":"Arch Dermatol"},{"issue":"June (4)","key":"10.1016\/j.burns.2017.03.016_bib0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.burns.2007.06.008","article-title":"Toxic epidermal necrolysis: use of Biobrane\u00ae or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients","volume":"34","author":"Boorboor","year":"2008","journal-title":"Burns"},{"issue":"March (3)","key":"10.1016\/j.burns.2017.03.016_bib0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/SAP.0b013e31806bf446","article-title":"A critical evaluation of the use of Biobrane\u00ae as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon","volume":"60","author":"Whitaker","year":"2008","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.burns.2017.03.016_bib0120","doi-asserted-by":"crossref","DOI":"10.1097\/01.sap.0000182652.88669.a6","article-title":"Biobrane\u00ae in the treatment of burns and scald injuries in children","volume":"55","author":"Lang","year":"2005","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.burns.2017.03.016_bib0125","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archsurg.1985.01390300081014","article-title":"Comparison of Biobrane\u00ae and Scarlet Red dressings for the management of donor site wounds","volume":"120","author":"Zapata-Sirvent","year":"1985","journal-title":"Arch Surg"},{"key":"10.1016\/j.burns.2017.03.016_bib0130","first-page":"661","article-title":"Therapeutic effects of Biobrane\u00ae in partial and full thickness thermal injury","volume":"100","author":"McHugh","year":"1986","journal-title":"Surgery"},{"key":"10.1016\/j.burns.2017.03.016_bib0135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archsurg.1984.01390170097019","article-title":"Improved treatment of the Stevens\u2013Johnson Syndrome","volume":"119","author":"Marvin","year":"1984","journal-title":"Arch Surg"},{"key":"10.1016\/j.burns.2017.03.016_bib0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","article-title":"10 year experience with toxic epidermal necrolysis","volume":"21","author":"Schulz","year":"2000","journal-title":"J Burn Care and Rehabil"},{"key":"10.1016\/j.burns.2017.03.016_bib0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004630-198103000-00006","article-title":"Human cadaver homograft in Toxic Epidermal Necrolysis","volume":"2","author":"Davidson","year":"1981","journal-title":"J Burn Care and Rehabil"},{"key":"10.1016\/j.burns.2017.03.016_bib0150","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1542\/peds.108.5.1162","article-title":"Treatment of extensive toxic epidermal necrolysis in children","volume":"108","author":"Spies","year":"2001","journal-title":"Pediatrics"},{"issue":"May\u2013June (3 Pt. 1)","key":"10.1016\/j.burns.2017.03.016_bib0155","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00004630-199505000-00020","article-title":"Use of Biobrane\u00ae in the treatment of toxic epidermal necrolysis","volume":"16","author":"Kucan","year":"1995","journal-title":"J Burn Care Rehabil"},{"issue":"January (1)","key":"10.1016\/j.burns.2017.03.016_bib0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-009-1659-1","article-title":"Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes","volume":"36","author":"Struck","year":"2010","journal-title":"Intensive Care Med"},{"issue":"August","key":"10.1016\/j.burns.2017.03.016_bib0165","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bjps.2014.04.003","article-title":"Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm","volume":"67","author":"Abela","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.burns.2017.03.016_bib0170","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","article-title":"A systematic review of toxic epidermal necrolysis treated in burns centres","volume":"40","author":"Mahar","year":"2014","journal-title":"Burns"},{"key":"10.1016\/j.burns.2017.03.016_bib0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0305-4179(88)90013-7","article-title":"A comparison of Biobrane\u00ae vs. homograft for coverage of contaminated burn wounds","volume":"14","author":"Gonce","year":"1988","journal-title":"Burns Incl Therm Inj"},{"key":"10.1016\/j.burns.2017.03.016_bib0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004630-199505000-00021","article-title":"Use of Biobrane\u00ae in management of scalds","volume":"16","author":"Demling","year":"1995","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.burns.2017.03.016_bib0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0305-4179(88)90219-7","article-title":"The toxic shock syndrome in a burn victim","volume":"14","author":"Egan","year":"1988","journal-title":"Burns Incl Therm Inj"},{"key":"10.1016\/j.burns.2017.03.016_bib0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0305-4179(06)80021-5","article-title":"Toxic shock syndrome associated with the use of Biobrane\u00ae in a scald burn victim","volume":"20","author":"Weinzweig","year":"1994","journal-title":"Burns"},{"key":"10.1016\/j.burns.2017.03.016_bib0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006534-200001000-00010","article-title":"Biobrane vs 1% silver sulphadiazine in second degree pediatric burns","volume":"105","author":"Barret Dziewulski","year":"2000","journal-title":"Plast Recons Surg"},{"issue":"25","key":"10.1016\/j.burns.2017.03.016_bib0200","article-title":"Experience with Biobrane: uses and caveats for success","volume":"9","author":"Greenwood","year":"2009","journal-title":"Eplasty"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417917301845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417917301845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T04:06:52Z","timestamp":1529467612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417917301845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0305417917301845"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2017.03.016","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of Biobrane\u00ae for wound coverage in Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2017.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}